
### [NCIT:C9235](http://purl.obolibrary.org/obo/NCIT_C9235)
**Label:** Systemic Mastocytosis

**Subclasses:** [NCIT:C9284](http://purl.obolibrary.org/obo/NCIT_C9284) (Systemic Mastocytosis with an Associated Hematological Neoplasm (SM-AHN)), [NCIT:C9285](http://purl.obolibrary.org/obo/NCIT_C9285) (Aggressive Systemic Mastocytosis), [NCIT:C3169](http://purl.obolibrary.org/obo/NCIT_C3169) (Mast Cell Leukemia), [NCIT:C43284](http://purl.obolibrary.org/obo/NCIT_C43284) (Primary Systemic Mastocytosis), [NCIT:C9348](http://purl.obolibrary.org/obo/NCIT_C9348) (Mast Cell Sarcoma), [NCIT:C8991](http://purl.obolibrary.org/obo/NCIT_C8991) (Malignant Mastocytosis), [NCIT:C9286](http://purl.obolibrary.org/obo/NCIT_C9286) (Indolent Systemic Mastocytosis), 

**Class expressions from DL-Learner:**

- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) 66.67%
- [NCIT:C43274](http://purl.obolibrary.org/obo/NCIT_C43274) (Leukemic Mast Cell) 58.33%
- [NCIT:C37063](http://purl.obolibrary.org/obo/NCIT_C37063) (Immature Malignant Mast Cell) 58.33%
- [NCIT:C25553](http://purl.obolibrary.org/obo/NCIT_C25553) (Leukemic Cell) and [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) 58.33%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38173](http://purl.obolibrary.org/obo/NCIT_C38173) (BCL2 Gene mRNA Overexpression))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38172](http://purl.obolibrary.org/obo/NCIT_C38172) (Cyclin D2 Messenger RNA Overexpression))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38171](http://purl.obolibrary.org/obo/NCIT_C38171) (PKCbeta1 Messenger RNA Overexpression))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38170](http://purl.obolibrary.org/obo/NCIT_C38170) (LMO2 Messenger RNA Overexpression))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38169](http://purl.obolibrary.org/obo/NCIT_C38169) (A-myb Messenger RNA Overexpression))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38168](http://purl.obolibrary.org/obo/NCIT_C38168) (BCL-6 Messenger RNA Overexpression))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38167](http://purl.obolibrary.org/obo/NCIT_C38167) (CD10 Messenger RNA Overexpression))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38158](http://purl.obolibrary.org/obo/NCIT_C38158) (Metachronous Wilms Tumor))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38157](http://purl.obolibrary.org/obo/NCIT_C38157) (Metachronous Osteosarcoma))) 57.49%
- [NCIT:C37062](http://purl.obolibrary.org/obo/NCIT_C37062) (Neoplastic Mast Cell) and (not ([NCIT:C38155](http://purl.obolibrary.org/obo/NCIT_C38155) (Recurrent Disease))) 57.49%


